Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Medifast Bolsters Growth Through Health & Wellness Solutions
01:26pm, Tuesday, 19'th Aug 2025
MED is expanding OPTAVIA, digital tools and wellness offerings to drive long-term growth and strengthen customer ties.
Medifast's Q2 Earnings Beat Estimates, Lower Revenues Hurt Margins
12:35pm, Tuesday, 05'th Aug 2025
MED's second-quarter 2025 earnings and sales decline as active earning OPTAVIA coaches dipped, hit by client acquisition.
Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript
11:56pm, Monday, 04'th Aug 2025
Medifast, Inc. (NYSE:MED ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Daniel R. Chard - Executive Chairman & CEO James P.
Medifast (MED) Q2 Revenue Falls 37%
05:59pm, Monday, 04'th Aug 2025
Medifast (MED) Q2 Revenue Falls 37%
Medifast Announces Second Quarter 2025 Financial Results
04:05pm, Monday, 04'th Aug 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarte
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
04:05pm, Monday, 21'st Jul 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quar
Medifast: Coach Surge Fuels Growth
02:48am, Thursday, 03'rd Jul 2025
Initiate Medifast with Strong Buy and $56 PT, citing overlooked operational inflection and coach network momentum driving above-consensus FY26 revenue growth. ASCEND product line and digital engagemen
Medifast (MED) Up 10.9% Since Last Earnings Report: Can It Continue?
12:35pm, Wednesday, 28'th May 2025
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y
10:01am, Tuesday, 29'th Apr 2025
MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.
Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript
06:03pm, Monday, 28'th Apr 2025
Medifast, Inc. (NYSE:MED ) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and CEO Jim Maloney -
Medifast Announces First Quarter 2025 Financial Results
04:05pm, Monday, 28'th Apr 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter
Medifast to Report Q1 Earnings: What Investors Should Expect
10:10am, Monday, 21'st Apr 2025
MED's first-quarter results may show challenges in customer acquisition amid market headwinds and shifting consumer trends.
Medifast Trades Near 52-Week Low: What's the Best Move Now?
12:10pm, Tuesday, 15'th Apr 2025
MED faces steep revenue declines and coach losses but aims to rebound through innovation, marketing and new GLP-1-focused initiatives.
Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect
09:21am, Friday, 28'th Mar 2025
Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition
01:05pm, Wednesday, 19'th Feb 2025
Medifast's Q2 results show challenges related to weak customer acquisition. However, it is prioritizing efforts to enhance coach productivity in the near term.
